Li Xiu Ying, aged 33, contracted hepatitis B through transmission from her mother at birth and is concerned about liver disease. After trips to both her primary care physician and a hospital-based liver specialist, she is advised a course of therapy with monthly follow-up appointments. But with a personalized approach to treatment, she would be able to receive tele-consultations at home, get results from blood tests within an hour, and receive a course of therapy based on her genetic makeup.  Watch the video below to see how Janssen Diagnostics envisions the future of hepatitis B treatment.